BIOMAT Database Logo BIOMAT Database Logo

A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone. 2017

Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao

Linear IgA bullous dermatosis is a rare autoimmune vesiculobullous disease characterized by linear deposition of IgA along the basement membrane zone. It is classically idiopathic, but may also arise secondary to drug exposure. A heterogeneous spectrum of clinical features has been described, including a rare, morbid variant mimicking toxic epidermal necrolysis. Herein, we present a case of vancomycin-induced linear IgA bullous dermatosis that manifested clinically as toxic epidermal necrolysis and resolved with dapsone therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013262 Stevens-Johnson Syndrome Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis. Drug-Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndrome,Epidermal Necrolysis, Toxic,Lyell's Syndrome,Mycoplasma-Induced Stevens Johnson Syndrome,Mycoplasma-Induced Stevens-Johnson Syndrome,Nonstaphylococcal Scalded Skin Syndrome,Scalded Skin Syndrome, Nonstaphylococcal,Stevens Johnson Syndrome Toxic Epidermal Necrolysis,Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Toxic Epidermal Necrolysis,Toxic Epidermal Necrolysis Stevens Johnson Syndrome,Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum,Drug Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndromes,Epidermal Necrolyses, Toxic,Lyell Syndrome,Lyell's Syndromes,Mycoplasma Induced Stevens Johnson Syndrome,Necrolyses, Toxic Epidermal,Necrolysis, Toxic Epidermal,Stevens Johnson Syndrome,Stevens-Johnson Syndrome, Drug-Induced,Stevens-Johnson Syndrome, Mycoplasma-Induced,Stevens-Johnson Syndromes, Drug-Induced,Syndrome, Lyell's,Syndrome, Mycoplasma-Induced Stevens-Johnson,Syndromes, Lyell's,Toxic Epidermal Necrolyses
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin
D062027 Linear IgA Bullous Dermatosis Autoimmune disease characterized by subepidermal blisters and linear deposition of autoantibodies at the dermoepidermal junction. The accumulated autoantibodies are of IMMUNOGLOBULIN A and occasionally IMMUNOGLOBULIN G classes against epidermal BASEMENT MEMBRANE proteins. The dermatosis is sometimes associated with malignancies and use of certain drugs (e.g., VANCOMYCIN). Chronic Bullous Disease of Childhood,Drug-induced Linear IgA Bullous Dermatosis,Drug-induced Linear IgA Dermatosis,Linear IgA Dermatosis,Linear IgA IgG Bullous Dermatosis,Linear IgA IgG Dermatosis,Dermatoses, Linear IgA,Dermatosis, Linear IgA,Drug induced Linear IgA Bullous Dermatosis,Drug induced Linear IgA Dermatosis,IgA Dermatoses, Linear,IgA Dermatosis, Linear,Linear IgA Dermatoses

Related Publications

Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Linear IgA Bullous Dermatosis Presenting as Toxic Epidermal Necrolysis.
November 2017, Actas dermo-sifiliograficas,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Vancomycin-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
January 2011, Indian journal of dermatology, venereology and leprology,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
May 2003, Journal of the American Academy of Dermatology,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
January 2001, Dermatology (Basel, Switzerland),
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis.
January 2014, Le Journal medical libanais. The Lebanese medical journal,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
August 2006, International journal of dermatology,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Purpura Fulminans Following Toxic Epidermal Necrolysis-Like Presentation of Spontaneous Linear IgA Bullous Disease.
January 2021, Cureus,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Linear IgA dapsone responsive bullous dermatosis.
May 1980, Journal of the Royal Society of Medicine,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
Phenytoin-induced linear IgA dermatosis mimicking toxic epidermal necrolysis.
November 2003, The Australasian journal of dermatology,
Julie K Nguyen, and Misha V Koshelev, and Bartley J Gill, and Jessica Boulavsky, and Abdul Hafeez Diwan, and Harry Dao
A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
December 2021, The Journal of dermatology,
Copied contents to your clipboard!